We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Chemical Works of Richter Gedeon PLC (PK) | USOTC:RGEDF | OTCMarkets | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 24.905 | 16.49 | 29.70 | 0.00 | 21:18:26 |
From Jul 2019 to Jul 2024
BUDAPEST--Pharmaceutical firm Richter Gedeon Nyrt., Hungary's largest home-grown drug maker signed a deal with US-based peer Evestra Inc on providing it with a $5 million convertible loan for drug development.
MAIN FACTS:
- The financing will help Evestra to accelerate the development of its women's health product pipeline into clinical stages.
- Under the terms of the agreement, after three years Richter has an option to decide whether the loan is to be reimbursed, including earned interest, or converted into an equity stake in Evestra.
- Evestra's products are based on medicinal chemistry and vaginal drug delivery technology, and address so far unmet medical needs in women's health areas.
Write to Veronika Gulyas at veronika.gulyas@wsj.com; Twitter: @VeronikaGulyas1
1 Year Chemical Works of Richte... (PK) Chart |
1 Month Chemical Works of Richte... (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
